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ABSTRACT 
Objective: to investigate the role of CT and MRI in 
diagnosis of Arnold chiari malformation of 
hydrocephalus and its treatment with VP shunt along 
with complications. 
Study Design: Prospective study 
Place and duration: Department of Neurosurgery, 
DG Khan Medical College from May 4, 2018 to May 
4, 2019. 
Methodology: Fifty patients of congenital 
hydrocephalus who were not treated previously were 
selected. Detailed history about disease and clinical 
examination of patients was performed. Follow ups 
were done at neurosurgery OPD. SPSS software for 
data analysis was used and mean ± SD, frequency and 
percentages were calculated for variables. P value 
≤0.05 was considered as significant. 
Results: Treatment in case of congenital 
hydrocephalus as VP shunt, intra-aneurysmal coiling, 
excision of meningomyelocele with VP shunt and 
suboccipital craniectomy + upper cervical 
laminectomy (scucl) were observed as 10%, 6%, 8% 
and 8% respectively.  Twelve percent of patients were 
not treated. 
Conclusion: CT and MRI are the main diagnostic 
tools for diagnosis of Arnold chiari malformation and 
VP shunt is the treatment of choice. Among 
complications of VP shunt infection of shunt and 
shunt block are the main complications.  
 
Introduction 
One of the most devastating and treatable type of 
neurological injury is hydrocephalus. It is also 
categorized as most common secondary neurological 
injury. (1) Unfortunately, in last four decades, 
treatment of hydrocephalus changed a little bit and 
remains complicated. From the middle of last century, 
valve regulated ventricular shunting is a treatment of 
choice for hydrocephalus. It is widely used treatment 
worldwide and continuous from last decades. (2, 3) 
Hydrocephalus considered as congenital anomaly like 
intraventricular hemorrhage and spina bifida that's 
why it has been considered as case of pediatric 
neurosurgeon. (4) Hydrocephalus now considered as 
chronic disease of child age. (5) In recent years, 
advancement in technologies like modern neuroscopy, 
telemetric flow and pressure monitoring, improves the 
method of hydrocephalus treatment but VP shunt is a 
new advancement and treatment of choice for Arnold 
chiari syndrome in hydrocephalus children. (6)  
In the previous literature, it was concluded that brain 
pathology will need to explore beyond the basic and 
cold management of previous century. (7, 8) First of 
all Rhazes describe the ventricular hydrocephalus and 
Vesalius describe a clear explanation of ventricular 
hydrocephalus in infants and concluded that enlarged 
heads could survive in older age. (9) Ventricular 
hydrocephalus or Arnold chiari malformation leads to 
the increased in intracranial pressure but in infants a 
natural body response adjusts this increase in ICP to 
the normal range. (10) In this study, main outcome 
variables were use of VP shunt for the treatment of 
Arnold chiari malformation and its associated 
complication. 
Materials and Methods 
This prospective study was conducted in the 
Department of Neurosurgery at DG Khan Medical 
College, Dera Ghazi Khan, Pakistan from 4th May 
2018 to 4th May 2019 under the supervision of senior 
neurosurgeon having 5 years experience in 
neurosurgery.  Study was started after the ethical 
approval from the ethical board of hospital. 
Nonprobability consecutive sampling was used. 
Diagnosed cases of Arnold chiari malformation were 
included in the study and the patients who were treated 
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Significance: 
One of the most devastating and treatable type of 
neurological injury is hydrocephalus. It is also 
categorized as most common secondary neurological 
injury. Ventricular hydrocephalus or Arnold chiari 
malformation leads to the increased in intracranial 
pressure but in infants a natural body response 
adjusts this increase in ICP to the normal range. In 
this study, main outcome variables were use of VP 
shunt for the treatment of Arnold chiari 
malformation and its associated complication. 
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previously with any surgical intervention were 
excluded from the study. A detailed physical and 
neurological examination, clinical history and routine 
investigation like CT scan and MRI and CSF analysis 
was performed. Complications associated with VP 
shunt were noted on a predesigned proforma. Follow 
ups were done in neurosurgery outdoor department 
periodically for the assessment of shunts, any 
neurological shunts, new and persistent symptoms and 
visual and motor symptoms. In case of malfunction of 
shunt, causes behind it evaluated. Data analysis was 
done by using SPSS version 23. Mean and standard 
deviations were determined for numerical variables 
like age and weight. Frequency and percentages were 
calculated for qualitative variables like gender and 
complications of VP shunt. 
Results: 
Fifty patients were included in this study. 
Investigations in case of congenital hydrocephalus as 
X-ray skull, USG skull, CT brain, MRI brain and MR 
angiography were noted as n=3 (6%), n=4 (8%), n=19 
(38%), n=6 (12%) and n=2 (4%), respectively. (Tabl1) 
Table 1: Investigations in case congenital 
hydrocephalus 
Investigation n , (%) 
X-ray skull n=3 (6%) 
USG skull n=4 (8%) 
CT brain 
n=19 
(38%) 
MRi brain n=6 (12%) 
MR angiography n=2 (4%) 
Treatment in case of congenital hydrocephalus as VP 
shunt, intra-aneurysmal coiling, excision of 
meningomyelocele with VP shunt and suboccipital 
craniectomy + upper cervical laminectomy (scucl) 
were observed as n=5 (10%), n=3 (6%), n=4 (8%) and 
n=4 (8%), respectively. While, n=6 (12%) patients 
were not treated. (Table 2) 
Table 2: Treatment of congenital hydrocephalus 
Treatment  n 
(%) 
VP shunt  
n=5 
(10%) 
Intra-aneurysmal coiling 
n=3 
(6%) 
Excision of meningomyelocele 
with VP shunt 
n=4 
(8%) 
Suboccipitalcraniectomy+upper 
cervical laminectomy (scucl)  
n=4 
(8%) 
Non treated  
n=6 
(12%) 
 
Complications of VP shunt as shunt infection, shunt 
block, transanal migration and intestinal perforation 
were noted as n=23 (46%), n=20 (40%), n=2 (4%) and 
n=3 (6%), respectively. (Table 3) 
Table 3: Complications in VP shunt 
Complications n , (%) 
Shunt infection 
n=23 (46%) 
Shunt block 
n=20 (40%) 
Transanal migration 
 n=02 (4%) 
Intestinal perforation 
 n=03 (6%) 
None 
n=14 (28%) 
Discussion 
Prevalence rate of hydrocephalus vary region to region 
and this anomaly sometime left with persistent 
neurological deficit. Many operative procedures have 
been performed in previous years with VP shunt for its 
management. (11) Blackburn et al estimated in his 
study prevalence rate of hydrocephalus 0.48 and 0.81 
per 1000 births. (12) 
Bondurant et al reported that about 4000 surgical 
operations were performed in Ireland and United 
Kingdom. This number is increasing day by day; 
United States also have huge economic burden of 
125,000 shunt surgeries every year. Estimated cost of 
this anomaly is 100 million dollars in America. (13) 
Feng et al reported in his study that if hydrocephalus 
left untreated it may complicate with visual loss, loss 
of cognitive function and motor development of poor 
motor function. (14) Aschoff et al conducted a similar 
study on this topic and conducted that if 
hydrocephalus left untreated it may persist and 
complicated with other symptoms. (15) 
In a study Kendre et al concluded that CT brain and 
MRI are the main diagnostic tools of hydrocephalus 
and VP shunt is the treatment of choice. Furthermore, 
VP shunts have some complication like infection of 
shunt and shunt block. This study is identical to the 
study findings in our report. (16) 
Treatment of hydrocephalus varies according to the 
causes of hydrocephalus, but VP shunt is the treatment 
of choice. Sandberg et al conducted a similar study 
and reported similar finding that treatment of Arnold 
Chiari hydrocephalus varies with the causes of disease. 
(17) In a study Caldareli et al reported that Arnold 
Chiari hydrocephalus has only treatment of choice 
ventricular shunting. VP shunting resolves all kinds of 
symptoms. (18) 
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In another study by Milhorat et al reported that 
improvement in symptoms of Arnold Chiari 
hydrocephalus is possible only with VP shunting or 
revision which is a standard and recommended 
treatment. (19) Another study was conducted by Lam 
CH et al reported 15.2% failure rate of VP shunt in 
adult hydrocephalus. This rate of failure is much lower 
than previous ratio that was reported 18% to 29% in 
different studies. (20)  
Conclusion 
CT and MRI are the main diagnostic tools for 
diagnosis of Arnold chiari malformation and VP shunt 
is the treatment of choice. Among complications of 
VP shunt infection of shunt and shunt block are the 
main complications.  
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